Medication Adjustments for Daytime Sleepiness and Inattention in ADHD/PTSD

Immediate Medication Changes

• The American Academy of Sleep Medicine recommends reducing or discontinuing quetiapine 25mg at bedtime, as it is a primary cause of daytime sedation, and then adding a stimulant medication for persistent daytime sleepiness if needed after reassessment 1, 2, 3
• Quetiapine 25mg at bedtime should be tapered and discontinued over 1-2 weeks, as guidelines explicitly state that quetiapine causes significant daytime sedation and weight gain, with insufficient evidence supporting its use for insomnia in patients without psychosis 1, 2
• If used for PTSD-related symptoms, gabapentin 300mg at night may contribute to daytime sedation and should be tapered and discontinued over 1-2 weeks if no clear therapeutic benefit 1

If Daytime Sleepiness Persists After Quetiapine Discontinuation

• The National Comprehensive Cancer Network recommends starting methylphenidate 2.5-5mg orally with breakfast, with a second dose at lunch if the morning dose wears off 2, 3
• Alternative wake-promoting agents include modafinil 100mg upon awakening, which can be increased weekly to 200-400mg daily as needed 3
• Caffeine up to 300mg daily can be used, with the last dose no later than 4:00 PM to avoid nighttime sleep interference 2, 3

Critical Safety Monitoring

• Before starting stimulants, check baseline blood pressure and heart rate, as stimulants can cause hypertension, palpitations, and arrhythmias, and obtain TSH, CBC, CMP, and LFTs to exclude metabolic causes of sleepiness 3
• Screen for sleep apnea using the Epworth Sleepiness Scale, as undiagnosed OSA would require CPAP before treating primary hypersomnia 4, 3

Common Pitfalls to Avoid

• The American Academy of Sleep Medicine and the National Comprehensive Cancer Network recommend avoiding benzodiazepines, as they worsen cognitive performance and daytime alertness in patients already experiencing inattention 1, 2
• Avoid zolpidem or other sedative-hypnotics for any residual sleep complaints, as they cause next-morning impairment 2
• The American Academy of Sleep Medicine recommends against using melatonin due to poor FDA regulation and inconsistent preparations in this population 3